BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22954126)

  • 1. Clinical characteristics of hereditary and sporadic medullary thyroid carcinoma.
    Xu L; Zhao YP; Wang WB; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):401-4. PubMed ID: 22954126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
    Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma.
    Raue F; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3582-e3591. PubMed ID: 33974051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
    Cardot-Bauters C; Leteurtre E; Leclerc L; Vantyghem MC; Do Cao C; Wemeau JL; d'Herbomez M; Carnaille B; Barbu V; Pinson S; Pigny P;
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
    Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
    Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
    Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma.
    Gimm O; Sutter T; Dralle H
    J Cancer Res Clin Oncol; 2001; 127(3):156-65. PubMed ID: 11260860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.
    Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Djurhuus BD; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C;
    Endocr Connect; 2018 Jun; 7(6):829-839. PubMed ID: 29760189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.
    Essig GF; Porter K; Schneider D; Arpaia D; Lindsey SC; Busonero G; Fineberg D; Fruci B; Boelaert K; Smit JW; Meijer JA; Duntas LH; Sharma N; Costante G; Filetti S; Sippel RS; Biondi B; Topliss DJ; Pacini F; Maciel RM; Walz PC; Kloos RT
    Thyroid; 2016 Nov; 26(11):1563-1572. PubMed ID: 27604949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
    Machens A; Hauptmann S; Dralle H
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary carcinoma of the thyroid: subtypes and current management.
    Randolph GW
    Compr Ther; 1996 Apr; 22(4):203-10. PubMed ID: 8733776
    [No Abstract]   [Full Text] [Related]  

  • 12. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk.
    Barbieri RB; Bufalo NE; Cunha LL; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):288-93. PubMed ID: 23278115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous medullary and papillary thyroid cancer: a novel entity?
    Machens A; Dralle H
    Ann Surg Oncol; 2012 Jan; 19(1):37-44. PubMed ID: 21626080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A; Lorenz K; Dralle H
    Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review.
    Fussey JM; Vaidya B; Kim D; Clark J; Ellard S; Smith JA
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):697-707. PubMed ID: 31301229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
    Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.
    Ruiz-Llorente S; Montero-Conde C; Milne RL; Moya CM; Cebrián A; Letón R; Cascón A; Mercadillo F; Landa I; Borrego S; Pérez de Nanclares G; Alvarez-Escolá C; Díaz-Pérez JA; Carracedo A; Urioste M; González-Neira A; Benítez J; Santisteban P; Dopazo J; Ponder BA; Robledo M;
    Cancer Res; 2007 Oct; 67(19):9561-7. PubMed ID: 17909067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.